Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
25 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/25/3048665/0/en/First-Patient-Dosed-in-Immutep-s-TACTI-004-Phase-III-Trial-in-First-Line-Non-Small-Cell-Lung-Cancer.html
20 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/20/3046165/0/en/Immutep-to-Present-Pivotal-TACTI-004-Trial-in-Progress-Poster-at-the-European-Lung-Cancer-Congress-2025.html
31 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/31/3018753/0/en/Immutep-Quarterly-Activities-Report-Q2-FY25.html
22 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/22/3013446/0/en/Patient-Enrolment-Completed-for-EFTISARC-NEO-Phase-II-Trial.html
06 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/06/3004565/0/en/Patient-Enrolment-Completed-for-INSIGHT-003.html
17 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/17/2998188/0/en/Immutep-Announces-Initial-Safety-Data-from-First-in-Human-Phase-I-Trial-Evaluating-IMP761.html
ABOUT THIS PAGE
Immutep is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Eftilagimod Alpha bulk offered by Immutep